Verastem gets orphan drug designation in the U.S.
July 24, 2013 at 13:05 PM EDT
A month after Verastem Inc. (Nasdaq: VSTM) got orphan drug designation in Europe for its potential drug to treat a rare form of lung cancer, the Cambridge biotech received the same designation in the U...
